FDA Inspection 1221751 — Contract Pharmaceuticals Limited Canada

Contract Pharmaceuticals Limited Canada — FEI 3001581899

The FDA completed an inspection of Contract Pharmaceuticals Limited Canada on November 3, 2023 in Mississauga. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 3, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Mississauga (Canada)

Citations

IDCFRDescription
202721 CFR 211.192Investigations of discrepancies, failures